Literature DB >> 12069981

Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.

Margareta Svensson1, Lennart E Nilsson, Magnus Ström, Maud Nilsson, Mikael Sörberg.   

Abstract

Pharmacodynamic studies of Helicobacter pylori exposed to metronidazole and tinidazole alone and in combination with clarithromycin were performed by bioluminescence assay of intracellular ATP. The pharmacodynamic parameter control-related effective regrowth time (CERT) was used. CERT is defined as the time required for the resumption of logarithmic growth and a return of the level of growth to the preexposure inoculum in the test culture minus the corresponding time in the control culture. CERT measures the combined effects of the initial level of killing and postantibiotic effect. The incubation times and drug concentrations were chosen according to their half-lives and their clinically achievable concentrations. The study shows that the parameter CERT is useful for the testing of antibiotic combinations. The CERTs induced by clarithromycin, metronidazole, and tinidazole alone and in the combinations tested were concentration dependent, with no maximum response, indicating that the use of high doses may be preferable. The combinations with the highest concentrations induced synergistic effects and prevented regrowth. The use of tinidazole in combination with clarithromycin proved to give the longest CERTs, indicating that this is the most effective combination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069981      PMCID: PMC127314          DOI: 10.1128/AAC.46.7.2244-2248.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Postantibiotic effect of meropenem on members of the family Enterobacteriaceae determined by five methods.

Authors:  F M MacKenzie; I M Gould; D G Chapman; D Jason
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

2.  Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.

Authors:  A Gotoh; Y Kawakami; T Akamatsu; T Katsuyama
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

3.  Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.

Authors:  E Svensson; H Hanberger; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Determination of in vitro postantibiotic effects in Staphylococcus aureus and Escherichia coli by [3H]thymidine incorporation.

Authors:  Magnús Gottfredsson; Helga Erlendsdóttir; Adalsteinn Gudmundsson; Sigurdur Gudmundsson
Journal:  Clin Microbiol Infect       Date:  1996       Impact factor: 8.067

5.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

6.  Penicillin-aminoglycoside synergy and post-antibiotic effect for enterococci.

Authors:  T G Winstanley; J G Hastings
Journal:  J Antimicrob Chemother       Date:  1989-02       Impact factor: 5.790

7.  Control-related effective regrowth time and post-antibiotic effect of meropenem on gram-negative bacteria studied by bioluminescence and viable counts.

Authors:  H Hanberger; E Svensson; L E Nilsson; M Nilsson
Journal:  J Antimicrob Chemother       Date:  1995-05       Impact factor: 5.790

8.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

9.  Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.

Authors:  G Cederbrant; G Kahlmeter; C Schalén; C Kamme
Journal:  J Antimicrob Chemother       Date:  1994-12       Impact factor: 5.790

10.  Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori.

Authors:  S J Veldhuyzen van Zanten; P T Pollak; H Kapoor; P K Yeung
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

View more
  1 in total

1.  Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan.

Authors:  Ayako Yanai; Kei Sakamoto; Masao Akanuma; Keiji Ogura; Shin Maeda
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.